As of 2025-11-17, the Relative Valuation of Avanos Medical Inc (AVNS) is (252.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.39 USD, the upside of Avanos Medical Inc based on Relative Valuation is -2313.0%.
The range of the Relative Valuation is (214.63) - (296.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 35.2x | 28.4x |
| Forward P/E multiples | 14.6x - 29.7x | 22.2x |
| Fair Price | (214.63) - (296.49) | (252.06) |
| Upside | -1984.4% - -2703.1% | -2313.0% |
| Date | P/E |
| 2025-11-14 | -1.14 |
| 2025-11-13 | -1.18 |
| 2025-11-12 | -1.18 |
| 2025-11-11 | -1.17 |
| 2025-11-10 | -1.15 |
| 2025-11-07 | -1.12 |
| 2025-11-06 | -1.12 |
| 2025-11-05 | -1.07 |
| 2025-11-04 | -1.13 |
| 2025-11-03 | -1.12 |
| 2025-10-31 | -1.11 |
| 2025-10-30 | -1.12 |
| 2025-10-29 | -1.14 |
| 2025-10-28 | -1.16 |
| 2025-10-27 | -1.17 |
| 2025-10-24 | -1.18 |
| 2025-10-23 | -1.18 |
| 2025-10-22 | -1.19 |
| 2025-10-21 | -1.16 |
| 2025-10-20 | -1.18 |
| 2025-10-17 | -1.15 |
| 2025-10-16 | -1.15 |
| 2025-10-15 | -1.13 |
| 2025-10-14 | -1.10 |
| 2025-10-13 | -1.09 |
| 2025-10-10 | -1.07 |
| 2025-10-09 | -1.13 |
| 2025-10-08 | -1.14 |
| 2025-10-07 | -1.13 |
| 2025-10-06 | -1.16 |
| 2025-10-03 | -1.18 |
| 2025-10-02 | -1.13 |
| 2025-10-01 | -1.15 |
| 2025-09-30 | -1.16 |
| 2025-09-29 | -1.16 |
| 2025-09-26 | -1.18 |
| 2025-09-25 | -1.16 |
| 2025-09-24 | -1.21 |
| 2025-09-23 | -1.20 |
| 2025-09-22 | -1.22 |
| 2025-09-19 | -1.19 |
| 2025-09-18 | -1.23 |
| 2025-09-17 | -1.19 |
| 2025-09-16 | -1.19 |
| 2025-09-15 | -1.23 |
| 2025-09-12 | -1.22 |
| 2025-09-11 | -1.24 |
| 2025-09-10 | -1.20 |
| 2025-09-09 | -1.24 |
| 2025-09-08 | -1.25 |